{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:52:28Z","timestamp":1794649948152,"version":"4.9.1"},"reference-count":53,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,11,18]],"date-time":"2018-11-18T00:00:00Z","timestamp":1542499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Asparaginase is essential in childhood acute lymphoblastic leukaemia (<jats:styled-content style=\"fixed-case\">ALL<\/jats:styled-content>) treatment, however hypersensitivity reactions to pegylated asparaginase (<jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\u2010asparaginase) hampers anti\u2010neoplastic efficacy. Patients with <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\u2010asparaginase hypersensitivity have been shown to possess zero asparaginase enzyme activity. Using this measurement to define the phenotype, we investigated genetic predisposition to <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\u2010asparaginase hypersensitivity in a genome\u2010wide association study (<jats:styled-content style=\"fixed-case\">GWAS<\/jats:styled-content>). From July 2008 to March 2016, 1494 children were treated on the Nordic Society of Paediatric Haematology and Oncology <jats:styled-content style=\"fixed-case\">ALL<\/jats:styled-content>2008 protocol. Cases were defined by clinical hypersensitivity and no enzyme activity, controls had enzyme activity \u2265 100 iu\/l and no hypersensitivity symptoms. <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\u2010asparaginase hypersensitivity was reported in 13\u00b78% (206\/1494) of patients. Fifty\u2010nine cases and 772 controls fulfilled <jats:styled-content style=\"fixed-case\">GWAS<\/jats:styled-content> inclusion criteria. The <jats:italic><jats:styled-content style=\"fixed-case\">CNOT<\/jats:styled-content>3<\/jats:italic> variant rs73062673 on 19q13.42, was associated with <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\u2010asparaginase allergy (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>4\u00b768\u00a0\u00d7\u00a010<jats:sup>\u22128<\/jats:sup>). We further identified two signals on chromosome 6 in relation to <jats:italic><jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">DQA<\/jats:styled-content>1<\/jats:italic> (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>9\u00b737\u00a0\u00d7\u00a010<jats:sup>\u22126<\/jats:sup>) and <jats:italic><jats:styled-content style=\"fixed-case\">TAP<\/jats:styled-content>2<\/jats:italic> (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>1\u00b759\u00a0\u00d7\u00a010<jats:sup>\u22125<\/jats:sup>). This study associated variants in <jats:italic><jats:styled-content style=\"fixed-case\">CNOT<\/jats:styled-content>3<\/jats:italic> and in the human leucocyte antigen (<jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>) region with <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\u2010asparaginase hypersensitivity, suggesting that not only genetic variations in the <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content> region, but also regulation of these genes are of importance in the biology of this toxicity. Furthermore, our study emphasizes the importance of using asparaginase enzyme activity measurements to identify <jats:styled-content style=\"fixed-case\">PEG<\/jats:styled-content>\u2010asparaginase hypersensitivity.<\/jats:p>","DOI":"10.1111\/bjh.15660","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T02:59:50Z","timestamp":1542596390000},"page":"405-417","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Genetic predisposition to <scp>PEG<\/scp>\u2010asparaginase hypersensitivity in children treated according to <scp>NOPHO ALL<\/scp>2008"],"prefix":"10.1111","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2695-8391","authenticated-orcid":false,"given":"Sofie G.","family":"H\u00f8jfeldt","sequence":"first","affiliation":[{"name":"Child and Adolescent Health Aarhus University Hospital Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2695-7244","authenticated-orcid":false,"given":"Benjamin O.","family":"Wolthers","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine University Hospital Rigshospitalet Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-7652","authenticated-orcid":false,"given":"Morten","family":"Tulstrup","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine University Hospital Rigshospitalet Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Abrahamsson","sequence":"additional","affiliation":[{"name":"Department of Paediatrics Institution for Clinical Sciences Sahlgrenska Academy University of Gothenburg Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramneek","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Bio\u2010 and Health Informatics Technical University of Denmark Kongens Lyngby Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Harila\u2010Saari","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's health Uppsala University Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Heyman","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's health Childhood Cancer Research Unit Karolinska University Hospital and Karolinska Institute Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-1538","authenticated-orcid":false,"given":"Louise T.","family":"Henriksen","sequence":"additional","affiliation":[{"name":"Child and Adolescent Health Aarhus University Hospital Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d2lafur G.","family":"J\u00f3nsson","sequence":"additional","affiliation":[{"name":"Children's Hospital Landspitali University Hospital Reykjavik Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi M.","family":"L\u00e4hteenm\u00e4ki","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Medicine Turku University Hospital and Turku University Turku Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendik","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Paediatrics St. Olavs Hospital Trondheim Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaie","family":"Pruunsild","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology University Children's Hospital Tallinn Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda","family":"Vaitkeviciene","sequence":"additional","affiliation":[{"name":"Clinic of Children's Diseases Faculty of Medicine Vilnius University Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine University Hospital Rigshospitalet Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte K.","family":"Albertsen","sequence":"additional","affiliation":[{"name":"Child and Adolescent Health Aarhus University Hospital Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Nordic Society of Paediatric Haematology Oncology (NOPHO) group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,18]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800100286"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2010.116"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22739"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0005"},{"key":"e_1_2_8_6_1","first-page":"4363","article-title":"In vitro and in\u00a0vivo killing of acute lymphoblastic leukemia cells by L\u2010asparaginase","volume":"49","author":"Asselin B.L.","year":"1989","journal-title":"Cancer Research"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1218004"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2694"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/1911114a0"},{"key":"e_1_2_8_10_1","first-page":"540","article-title":"Differentiating hypersensitivity versus infusion\u2010 related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia","volume":"59","author":"Burke M.J.","year":"2016","journal-title":"Leukemia & Lymphoma"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.94"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2012.12.018"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2508"},{"key":"e_1_2_8_14_1","first-page":"3893","article-title":"Effective dose of L\u2010asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group","volume":"39","author":"Ertel I.J.","year":"1979","journal-title":"Cancer Research"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-563742"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-628800"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.09.027"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.09.029"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2653"},{"key":"e_1_2_8_20_1","first-page":"18","article-title":"Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease","volume":"7","author":"eGTEx Project","year":"2017","journal-title":"Nature Genetics"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26200"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(69)90375-X"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12865"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1101098"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2686"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7304"},{"key":"e_1_2_8_27_1","first-page":"942","article-title":"L\u2010asparaginase in the treatment of neoplastic diseases in children","volume":"31","author":"Jaffe N.","year":"1971","journal-title":"Cancer Research"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26123"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.168211"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-2697(02)00232-4"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3236-y"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-601"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.11.018"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv402"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02187.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.162"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25489"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26884"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/519795"},{"key":"e_1_2_8_40_1","unstructured":"R Core Team. (2017).R: A language and environment for statistical computing.R Foundation for Statistical Computing Vienna Austria. Available athttp:\/\/www.R-project.org\/(Accessed August 28 2018)."},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181e6f003"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03708-7"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1211"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245951"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.137380"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.143"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature15394"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12097"},{"key":"e_1_2_8_49_1","first-page":"796","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1\u201045\u00a0years with acute lymphoblastic leukemia","volume":"124","author":"Toft N.","year":"2017","journal-title":"Leukemia"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-534347"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26686"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0157-1"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080941"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0621-5"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.15660","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T08:30:22Z","timestamp":1694680222000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.15660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,18]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1111\/bjh.15660"],"URL":"https:\/\/doi.org\/10.1111\/bjh.15660","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,18]]},"assertion":[{"value":"2018-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}